Key Developments: Greatbatch Inc (GB)

GB on New York Consolidated

55.92USD
27 Mar 2015
Change (% chg)

$0.44 (+0.79%)
Prev Close
$55.48
Open
$55.39
Day's High
$56.06
Day's Low
$55.23
Volume
51,060
Avg. Vol
110,798
52-wk High
$56.82
52-wk Low
$42.23

Search Stocks

Latest Key Developments (Source: Significant Developments)

Greatbatch Inc gives FY 2015 guidance; EPS guidance above analysts' estimates
Tuesday, 24 Feb 2015 04:05pm EST 

Greatbatch Inc:Expects FY 2015 sales guidance, excluding plans for Algovita, of $715-$730 million and adjusted diluted EPS guidance of $2.61-$2.71.FY 2015 revenue of $730 million and EPS of $2.60 - Thomson Reuters I/B/E/S.  Full Article

Greatbatch Inc gives FY 2015 outlook
Thursday, 15 Jan 2015 09:00am EST 

Greatbatch Inc:Expects FY 2015 revenue growth in the range of 4 pct to 6 pct.Expects FY 2015 adjusted operating income as a pct of sales in the range of 30 - 50 bps improvement to 13.7 pct - 14.0 pct.Expects FY 2015 adjusted diluted EPS of about two times revenue growth.FY 2015 revenue of $732.37 mln, EBIT of $102.18 mln and EPS of $2.60 - Thomson Reuters I/B/E/S.  Full Article

Greatbatch Inc raises low end of prior FY 2014 revenue guidance; raises FY 2014 EPS guidance
Thursday, 30 Oct 2014 04:08pm EDT 

Greatbatch Inc:Raises FY 2014 revenue and adjusted diluted earnings per share guidance range to $695 million - $705 million and $2.32 - $2.38 per share, respectively.FY 2014 revenue of $700 million and EPS of $2.32 - Thomson Reuters I/B/E/S.  Full Article

Greatbatch Inc acquires CCC Medical Devices
Tuesday, 12 Aug 2014 02:11pm EDT 

Greatbatch Inc:Announced that it has acquired CCC Medical Devices (CCC), globally-respected active implantable medical device (AIMD) systems developer and manufacturer.Acquisition effective immediately.Based in Montevideo, Uruguay, CCC designs and produces range of devices for some of world's top medical device companies, including implantable pulse generators, programmer systems, battery chargers, patient wands and leads.  Full Article

Greatbatch Inc reaffirms FY 2014 guidance
Thursday, 31 Jul 2014 04:17pm EDT 

Greatbatch Inc:Confirms FY 2014 revenue and adjusted diluted EPS guidance provided at the beginning of year.Expects FY 2014 sales in the range of $685 - $705 million.Expects FY 2014 GAAP Diluted EPS in the range of $1.94 - $1.99.Expects FY 2014 Adjusted Diluted EPS in the range of $2.25 - $2.35.FY 2014 revenue of $705 million and EPS of $2.33 - Thomson Reuters I/B/E/S.  Full Article

Greatbatch Inc sees FY 2014 guidance at upper end of prior range
Wednesday, 30 Apr 2014 04:05pm EDT 

Greatbatch Inc:Expects FY 2014 guidance at the upper end of 3pct to 6pct organic constant currency revenue growth and 7pct to 12pct adjusted diluted EPS improvement.Reported revenue of $663.9 million and EPS of $2.10 in FY 2013.FY 2014 revenue of $694.6 million and EPS of $2.32 - Thomson Reuters I/B/E/S.  Full Article

Greatbatch Inc reaffirms FY 2014 guidance
Monday, 24 Feb 2014 04:20pm EST 

Greatbatch Inc:Confirms FY 2014 guidance of 3 to 6 percentage organic constant currency revenue growth and 7 to 12 percentage adjusted diluted EPS improvement.The company reported revenue of $663.9 million and EPS of $2.10 in FY 2013.FY 2014 revenue of $690 million and EPS of $2.31 - Thomson Reuters I/B/E/S.  Full Article

Greatbatch Inc Sees FY 2013 Revenue Guidance At Lower End Of Prior Range; Sees FY 2013 EPS Guidance At Mid-Point Or Better Prior Range
Thursday, 24 Oct 2013 04:05pm EDT 

Greatbatch Inc announced that based upon its results for the first three quarters, as well as the Company's expectations for the remainder of 2013, the Company continue to believe that revenue for fiscal 2013 to be at the lower end of its original sales guidance of $660 million to $680 million provided at the beginning of the year. If achieved, this would result in organic revenue growth of 5% - 8% after adjusting for the disposition of $15 million of non-core orthopaedic product lines at the end of 2012. Because of the Company's strong productivity performance and favorable mix of product sales the Company believe that its adjusted diluted EPS will be at the mid-point or better of its previous $2.05 to $2.15 guidance. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $664 million and EPS of $2.09 for fiscal 2013  Full Article

Greatbatch Inc Raises FY 2013 EPS Guidance; Reaffirms FY 2013 Revenue Guidance
Thursday, 25 Jul 2013 04:05pm EDT 

Greatbatch Inc announced that based upon its results for the first half of the year, as well as its expectations for the remainder of 2013, at this time the Company raising its 2013 adjusted diluted EPS guidance ranges to $2.05 to $2.15 per share from the previously communicated $2.00 to $2.05 per share. For fiscal 2013, the Company continue to believe that revenue will be at the lower end of its original sales guidance of $660 million to $680 million provided at the beginning of the year. If achieved, this would result in organic revenue growth of 5% - 8% after adjusting for the disposition of $15 million of non-core orthopaedic product lines at the end of 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $1.98 and revenue of $661 million for fiscal 2013.  Full Article

Greatbatch Inc's Greatbatch Ltd Files Patent Infringement Complaint Against AVX Corp In Federal Court
Friday, 26 Apr 2013 04:28pm EDT 

Greatbatch Ltd., a wholly owned subsidiary of Greatbatch Inc., announced that it has filed a complaint in the U.S. District Court for the District of Delaware against AVX Corp and AVX Filter Corporation. The complaint alleges that AVX has infringed a Greatbatch patent by manufacturing and selling filtered feedthrough assemblies used in implantable pacemakers and cardioverter defibrillators that incorporate its patented technology. US Patent 5,905,627 was issued to Richard Brendel and Robert Stevenson for an invention entitled Internally Grounded Feedthrough Filter Capacitor. The invention shields and decouples the terminal pins in implantable medical devices to prevent interference from externally generated electromagnetic fields from devices such as mobile phones. Greatbatch took ownership of key patents in this field when the Company acquired Maxwell Electronics Group Inc. of Carson City, Nevada in 2001.  Full Article

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters March 02, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, now click on Related Co Data, now click on Co Events.

Search Stocks